Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
East Lampeter Township, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- High Real Estate Group LLC (HREG), the Pennsylvania Department of Transportation (PennDOT), county and township officials and local...
-
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination,...
-
WASHINGTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Agricultural Micronutrients Market is valued at USD 4229.28 Million in 2022 and is expected to reach USD 7828.10 Million by 2030 at a CAGR of 8%...
-
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory and neuroprotective properties through modulation of the ATP-adenosine axis – ...
-
Pune, India, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The global pilot training market size was valued at USD 7.07 billion in 2022 and is projected to grow from USD 8.09 billion in 2023 to USD 20.02...
-
Results showed antineoplastic activity in pancreatic tumor cell lines Metabolic and transcriptional findings demonstrate a molecular basis to reduce tumor cell proliferation and induce apoptotic cell...
-
CALGARY, Alberta, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Today the Calgary National Bank Challenger (The Challenger or The Tournament), held at the Osten & Victor Alberta Tennis Centre (ATC)...
-
- Preclinical data demonstrates AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity and evidence of anti-inflammatory and neuroprotective properties – -...
-
LONDON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- HotelPlanner, a leading travel technology company and hotel booking platform, today announced four new brand sponsorships for British professional tennis...
-
IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...